TScan Therapeutics had a revenue of 2.51M in the quarter ending Sep 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 21.87M, Decreased 214.15%. In the fiscal year ending Dec 31, 2024, TScan Therapeutics had annual revenue of 2.82M with -86.62% growth.